SCHEMBL13523218

SCHEMBL13523218

Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4[nH]nc(C)c34)cc2)c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 19/20 0.82
KIT P10721 8/20 0.82
FLT3 P36888 8/20 0.82
CSF1R P07333 7/20 0.82
FLT1 P17948 7/20 0.82
FLT4 P35916 7/20 0.82
LYN P07948 6/20 0.82
BLK P51451 6/20 0.82
LCK P06239 6/20 0.82
SRC P12931 5/20 0.82
FYN P06241 4/20 0.82
PDGFRB P09619 4/20 0.64
FGFR1 P11362 3/20 0.64
PDGFRA P16234 3/20 0.64
ABL1 P00519 3/20 0.64
AURKA O14965 3/20 0.64
AURKB Q96GD4 3/20 0.64
MAPK13 O15264 2/20 0.64
DYRK3 O43781 2/20 0.64
ROCK2 O75116 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1702794 0.90 KDR (1.00) KDRKITFLT3CSF1RFLT1
SCHEMBL13209956 0.89 KDR (0.80) KDRKITFLT3CSF1RFLT1
SCHEMBL13523220 0.84 KDR (0.81) KDRKITFLT3CSF1RFLT1
SCHEMBL13873001 0.83 KDR (0.69) KDRKITFLT3CSF1RFLT1
SCHEMBL13523215 0.80 KDR (0.83) KDRKITFLT3CSF1RFLT1
Linifanib SCHEMBL93804 0.78 KDR (1.00) KDRKITFLT3CSF1RFLT1
Linifanib SCHEMBL29375368 0.78 KDR (1.00) KDRKITFLT3CSF1RFLT1
SCHEMBL6073436 0.78 KDR (0.79) KDRKITFLT3CSF1RFLT1
SCHEMBL12426039 0.77 KDR (0.77) KDRKITFLT3CSF1RFLT1
SCHEMBL1702799 0.77 KDR (1.00) KDRKITFLT3CSF1RFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004306-A1 PIGF-1 Assay and kits and components thereof ABBOTT LABORATORIES (US) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004306-A1 PIGF-1 Assay and kits and components thereof PGF, FLT1, HDGF KDR 9/4885KIT 140/4885FLT3 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.